title: All together now?
abstract: The imminent advent of a global exchange is unlikely to be a panacea for the financial ills that currently beset European biotech.
mesh_terms: D001709:Biotechnology / Q000191:economics*; D005060:Europe; D005062:European Union / Q000191:economics*; D007391:International Cooperation; D007449:Investments / Q000458:organization & administration*; D014481:United States